Buckingham Strategic Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.99M | Sell |
12,765
-251
| -2% | -$73.7K | 0.04% | 169 |
|
|
2024
Q1 | $3.7M | Sell |
13,016
-4,283
| -25% | -$1.25M | 0.04% | 170 |
|
|
2023
Q4 | $4.98M | Sell |
17,299
-1,500
| -8% | -$409K | 0.06% | 140 |
|
|
2023
Q3 | $5.05M | Sell |
18,799
-1,945
| -9% | -$485K | 0.07% | 130 |
|
|
2023
Q2 | $4.61M | Buy |
20,744
+7,061
| +52% | +$1.64M | 0.07% | 140 |
|
|
2023
Q1 | $3.59M | Hold |
13,683
| – | – | 0.07% | 136 |
|
|
2022
Q4 | $3.59M | Buy |
13,683
+211
| +2% | +$56.6K | 0.07% | 136 |
|
|
2022
Q3 | $3.04M | Sell |
13,472
-1,411
| -9% | -$342K | 0.06% | 137 |
|
|
2022
Q2 | $3.62M | Sell |
14,883
-9
| -0.1% | -$2.21K | 0.07% | 125 |
|
|
2022
Q1 | $3.6M | Buy |
14,892
+291
| +2% | +$66.9K | 0.07% | 129 |
|
|
2021
Q4 | $3.29M | Buy |
14,601
+1,672
| +13% | +$353K | 0.06% | 138 |
|
|
2021
Q3 | $2.75M | Buy |
12,929
+418
| +3% | +$96.2K | 0.06% | 146 |
|
|
2021
Q2 | $3.05M | Buy |
12,511
+997
| +9% | +$245K | 0.07% | 139 |
|
|
2021
Q1 | $2.87M | Sell |
11,514
-3,541
| -24% | -$845K | 0.14% | 123 |
|
|
2020
Q4 | $3.46M | Buy |
15,055
+3,876
| +35% | +$894K | 0.18% | 105 |
|
|
2020
Q3 | $2.84M | Buy |
11,179
+218
| +2% | +$54K | 0.22% | 86 |
|
|
2020
Q2 | $2.58M | Sell |
10,961
-7,412
| -40% | -$1.69M | 0.25% | 84 |
|
|
2020
Q1 | $3.73M | Buy |
18,373
+5,222
| +40% | +$1.14M | 0.36% | 59 |
|
|
2019
Q4 | $3.17M | Buy |
13,151
+885
| +7% | +$195K | 0.3% | 72 |
|
|
2019
Q3 | $2.37M | Buy |
12,266
+86
| +0.7% | +$16.5K | 0.26% | 79 |
|
|
2019
Q2 | $2.24M | Buy |
12,180
+1,008
| +9% | +$180K | 0.24% | 80 |
|
|
2019
Q1 | $2.12M | Buy |
11,172
+449
| +4% | +$85.7K | 0.27% | 81 |
|
|
2018
Q4 | $2.09M | Buy |
10,723
+100
| +0.9% | +$19.5K | 0.32% | 65 |
|
|
2018
Q3 | $2.2M | Sell |
10,623
-2,955
| -22% | -$582K | 0.34% | 63 |
|
|
2018
Q2 | $2.51M | Buy |
13,578
+6,169
| +83% | +$1.09M | 0.41% | 52 |
|
|
2018
Q1 | $1.26M | Sell |
7,409
-3,151
| -30% | -$578K | 0.25% | 89 |
|
|
2017
Q4 | $1.84M | Buy |
10,560
+709
| +7% | +$125K | 0.38% | 59 |
|
|
2017
Q3 | $1.84M | Buy |
9,851
+477
| +5% | +$84.5K | 0.44% | 54 |
|
|
2017
Q2 | $1.61M | Buy |
9,374
+1,433
| +18% | +$233K | 0.38% | 63 |
|
|
2017
Q1 | $1.3M | Buy |
7,941
+341
| +4% | +$56.7K | 0.38% | 51 |
|
|
2016
Q4 | $1.11M | Buy |
7,600
+583
| +8% | +$87.7K | 0.36% | 59 |
|
|
2016
Q3 | $1.17M | Sell |
7,017
-177
| -2% | -$29.9K | 0.4% | 53 |
|
|
2016
Q2 | $1.09M | Sell |
7,194
-14
| -0.2% | -$2.18K | 0.37% | 55 |
|
|
2016
Q1 | $1.08M | Buy |
7,208
+206
| +3% | +$30.6K | 0.36% | 57 |
|
|
2015
Q4 | $1.14M | Sell |
7,002
-181
| -3% | -$28.5K | 0.38% | 51 |
|
|
2015
Q3 | $994K | Buy |
7,183
+925
| +15% | +$146K | 0.35% | 56 |
|
|
2015
Q2 | $961K | Sell |
6,258
-86
| -1% | -$13.8K | 0.32% | 59 |
|
|
2015
Q1 | $1.01M | Buy |
6,344
+100
| +2% | +$15.7K | 0.38% | 50 |
|
|
2014
Q4 | $995K | Buy |
6,244
+27
| +0.4% | +$4.21K | 0.38% | 51 |
|
|
2014
Q3 | $873K | Buy |
6,217
+498
| +9% | +$65K | 0.36% | 51 |
|
|
2014
Q2 | $677K | Buy |
5,719
+111
| +2% | +$12.8K | 0.3% | 63 |
|
|
2014
Q1 | $692K | Buy |
5,608
+840
| +18% | +$102K | 0.32% | 57 |
|
|
2013
Q4 | $544K | Sell |
4,768
-127
| -3% | -$14.4K | 0.26% | 64 |
|
|
2013
Q3 | $548K | Buy |
4,895
+100
| +2% | +$10.8K | 0.29% | 61 |
|
|
2013
Q2 | $473K | Buy |
+4,795
| New | +$498K | 0.27% | 63 |
|
Other funds holding AMGN
Buckingham Strategic Wealth's AMGN Position: Q2 2024 in Review
Buckingham Strategic Wealth reduced its Amgen (AMGN) stake by 1.9% in Q2 2024, selling an estimated $73.7K and leaving 12,765 shares worth $3.99M. The position accounts for 0.04% of the portfolio, ranked #169.
Buckingham Strategic Wealth first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $5.05M in Q3 2023. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Buckingham Strategic Wealth held 12,765 shares of Amgen worth $3.99M as of Q2 2024.
- Buckingham Strategic Wealth sold 251 Amgen shares in Q2 2024, an estimated $73.7K.
- Amgen made up 0.04% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #169 holding.
- Buckingham Strategic Wealth first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
- Buckingham Strategic Wealth's Amgen position peaked at $5.05M in Q3 2023.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.